-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Neutropenia is a hematological toxicity related to bone marrow suppression caused by chemotherapy.
The degree and duration of its reduction are closely related to the risk of infection and even death
.
Recombinant human granulocyte colony stimulating factor (rhG-CSF) has been on the market for many years as an effective drug to prevent and treat neutropenia caused by tumor radiotherapy and chemotherapy
We sincerely welcome valuable comments and suggestions from all walks of life on the solicitation draft, and timely feedback to us for follow-up improvement
.
The time limit for soliciting opinions is 1 month from the date of publication
Please send your feedback to the mailbox of the following contact:
Contact: Zhang Hong
Contact: zhanghong@cde.
Thank you for your participation and great support
Drug Evaluation Center
October 11, 2021
Appendix:
1 "Long-acting Granulocyte Colony Stimulating Factor to Prevent Infection after Chemotherapy Clinical Trial Design Technical Guidelines (Draft for Solicitation of Comments)".
"Long-acting Granulocyte Colony Stimulating Factor to Prevent Infection after Chemotherapy Clinical Trial Design Technical Guidelines (Draft for Solicitation of Comments)".
"Technical Guidelines for the Design of Long-acting Granulocyte Colony Stimulating Factor to Prevent Infection after Chemotherapy (Draft for Comment)" Drafting Instructions.
"Long-acting Granulocyte Colony Stimulating Factor Clinical Trial Design Technical Guidelines for the Prevention of Infection after Chemotherapy (Draft for Solicitation of Comments)" feedback form for soliciting opinions.
docx